Literature DB >> 27814604

Sphingolipids in obesity and related complications.

Krishna M Boini1, Min Xia2, Saisudha Koka3, Todd W B Gehr4, Pin-Lan Li5.   

Abstract

Sphingolipids are biologically active lipids ubiquitously produced in all vertebrate cells. Asides from structural components of cell membrane, sphingolipids also function as intracellular and extracellular mediators that regulate many important physiological cellular processes including cell survival, proliferation, apoptosis, differentiation, migration and immune processes. Recent studies have also indicated that disruption of sphingolipid metabolism is strongly associated with different diseases that exhibit diverse neurological and metabolic consequences. Here, we briefly summarize current evidence for understanding of sphingolipid pathways in obesity and associated complications. The regulation of sphingolipids and their enzymes may have a great impact in the development of novel therapeutic modalities for a variety of metabolic diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27814604      PMCID: PMC5844360          DOI: 10.2741/4474

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  107 in total

Review 1.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 2.  The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity.

Authors:  E W Kraegen; G J Cooney; J M Ye; A L Thompson; S M Furler
Journal:  Exp Clin Endocrinol Diabetes       Date:  2001       Impact factor: 2.949

3.  Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients.

Authors:  Hazel Huang; Takhar Kasumov; Patrick Gatmaitan; Helen M Heneghan; Sangeeta R Kashyap; Philip R Schauer; Stacy A Brethauer; John P Kirwan
Journal:  Obesity (Silver Spring)       Date:  2011-05-05       Impact factor: 5.002

4.  Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1.

Authors:  Charmi Shah; Guang Yang; Ian Lee; Jacek Bielawski; Yusuf A Hannun; Fahumiya Samad
Journal:  J Biol Chem       Date:  2008-03-22       Impact factor: 5.157

5.  Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells.

Authors:  Darren J Powell; Sophie Turban; Alexander Gray; Eric Hajduch; Harinder S Hundal
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

6.  Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.

Authors:  Johannes Kornhuber; Philipp Tripal; Martin Reichel; Lothar Terfloth; Stefan Bleich; Jens Wiltfang; Erich Gulbins
Journal:  J Med Chem       Date:  2007-11-21       Impact factor: 7.446

Review 7.  The role and metabolism of sulfatide in the nervous system.

Authors:  Matthias Eckhardt
Journal:  Mol Neurobiol       Date:  2008-05-09       Impact factor: 5.590

8.  Weight-reducing effects of the plasma protein encoded by the obese gene.

Authors:  J L Halaas; K S Gajiwala; M Maffei; S L Cohen; B T Chait; D Rabinowitz; R L Lallone; S K Burley; J M Friedman
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

9.  Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.

Authors:  Tae-Sik Park; Robert L Panek; Sandra Bak Mueller; Jeffrey C Hanselman; Wendy S Rosebury; Andrew W Robertson; Erick K Kindt; Reynold Homan; Sotirios K Karathanasis; Mark D Rekhter
Journal:  Circulation       Date:  2004-11-15       Impact factor: 29.690

10.  Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition.

Authors:  Elias N Glaros; Woojin S Kim; Brett Garner
Journal:  Clin Sci (Lond)       Date:  2010-03-30       Impact factor: 6.124

View more
  14 in total

1.  Influence of the Human Lipidome on Epicardial Fat Volume in Mexican American Individuals.

Authors:  Ana Cristina Leandro; Laura F Michael; Marcio Almeida; Mikko Kuokkanen; Kevin Huynh; Corey Giles; Thy Duong; Vincent P Diego; Ravindranath Duggirala; Geoffrey D Clarke; John Blangero; Peter J Meikle; Joanne E Curran
Journal:  Front Cardiovasc Med       Date:  2022-06-06

Review 2.  Role of ceramides in the pathogenesis of diabetes mellitus and its complications.

Authors:  Nawajes Mandal; Richard Grambergs; Koushik Mondal; Sandip K Basu; Faiza Tahia; Sam Dagogo-Jack
Journal:  J Diabetes Complications       Date:  2020-09-16       Impact factor: 2.852

3.  Gut microbiome variation modulates the effects of dietary fiber on host metabolism.

Authors:  Sofia M Murga-Garrido; Qilin Hong; Tzu-Wen L Cross; Evan R Hutchison; Jessica Han; Sydney P Thomas; Eugenio I Vivas; John Denu; Danilo G Ceschin; Zheng-Zheng Tang; Federico E Rey
Journal:  Microbiome       Date:  2021-05-20       Impact factor: 14.650

Review 4.  Mycotoxin: Its Impact on Gut Health and Microbiota.

Authors:  Winnie-Pui-Pui Liew; Sabran Mohd-Redzwan
Journal:  Front Cell Infect Microbiol       Date:  2018-02-26       Impact factor: 5.293

Review 5.  Sphingolipids in Obesity and Correlated Co-Morbidities: The Contribution of Gender, Age and Environment.

Authors:  Enrica Torretta; Pietro Barbacini; Nasser M Al-Daghri; Cecilia Gelfi
Journal:  Int J Mol Sci       Date:  2019-11-24       Impact factor: 5.923

Review 6.  Sphingolipids in the Heart: From Cradle to Grave.

Authors:  Anna Kovilakath; Maryam Jamil; Lauren Ashley Cowart
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-15       Impact factor: 5.555

7.  Paediatric obesity: a systematic review and pathway mapping of metabolic alterations underlying early disease processes.

Authors:  Margot De Spiegeleer; Ellen De Paepe; Lieven Van Meulebroek; Inge Gies; Jean De Schepper; Lynn Vanhaecke
Journal:  Mol Med       Date:  2021-11-06       Impact factor: 6.354

Review 8.  Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity.

Authors:  Gabriel Pasquarelli-do-Nascimento; Heloísa Antoniella Braz-de-Melo; Sara Socorro Faria; Igor de Oliveira Santos; Gary P Kobinger; Kelly Grace Magalhães
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-28       Impact factor: 5.555

9.  The Effect of a High-Fat Diet on the Fatty Acid Composition in the Hearts of Mice.

Authors:  Alicja Pakiet; Agnieszka Jakubiak; Paulina Mierzejewska; Agata Zwara; Ivan Liakh; Tomasz Sledzinski; Adriana Mika
Journal:  Nutrients       Date:  2020-03-20       Impact factor: 5.717

Review 10.  Evaluating Possible Mechanisms Linking Obesity to COVID-19: a Narrative Review.

Authors:  Maryam Vasheghani; Zahra Hessami; Mahsa Rekabi; Atefeh Abedini; Akram Qanavati
Journal:  Obes Surg       Date:  2022-02-03       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.